Patents by Inventor Marcus Boehm

Marcus Boehm has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240059667
    Abstract: Methods are provided for modulating MRGPRX2 generally, or for treating a MRGPRX2 or a MRGPRX2 ortholog dependent condition, more specifically, by contacting the MRGPRX2 or the MRGPRX2 ortholog by administering to a subject in need thereof, respectively, an effective amount of a compound having structure (I): or a pharmaceutically acceptable salt, isomer, hydrate, solvate or isotope thereof, wherein W, Z, R1, R2, R3, R4, R5, R6 and Rx are as defined herein. Pharmaceutical compositions containing such compounds, as well as the compounds themselves, are also provided.
    Type: Application
    Filed: March 29, 2023
    Publication date: February 22, 2024
    Inventors: Marion Lanier, Marcus Boehm, Liming Huang, Esther Martinborough, Marcos Sainz, Brandon Selfridge, Adam Yeager
  • Patent number: 11840521
    Abstract: Methods are provided for modulating MRGPR X4 generally, or for treating a MRGPR X4 dependent condition more specifically, by contacting the MRGPR X4 or administering to a subject in need thereof, respectively, an effective amount of a compound having the structure of Formula (I): or a pharmaceutically acceptable isomer, racemate, hydrate, solvate, isotope, or salt thereof, wherein n, x, A, Q1, Q2, Z, R, R1, R2, R3, R4 and R5 are as defined herein. Pharmaceutical compositions containing such compounds, as well as to compounds themselves, are also provided.
    Type: Grant
    Filed: July 6, 2022
    Date of Patent: December 12, 2023
    Assignee: Escient Pharmaceuticals, Inc.
    Inventors: Adam Yeager, Brandon Selfridge, Marcos Sainz, Esther Martinborough, Marcus Boehm, Liming Huang
  • Publication number: 20230369177
    Abstract: A molded semiconductor package includes: a mold compound; a metal substrate partly embedded in the mold compound; at least one first metal lead partly embedded in the mold compound; an inlay embedded in the mold compound, the inlay comprising a semiconductor die embedded in an electrically insulating body, a first metal structure attached to a first side of the semiconductor die, and a second metal structure attached to a second side of the semiconductor die; and a metal clip at least partly embedded in the mold compound and connecting the second metal structure to the at least one first metal lead. The semiconductor die has a maximum junction temperature higher than a glass transition temperature of the mold compound, the electrically insulating body has a glass transition temperature at or above the maximum junction temperature of the semiconductor die, and the metal substrate is attached to the first metal structure.
    Type: Application
    Filed: May 10, 2022
    Publication date: November 16, 2023
    Inventors: Marcus Boehm, Michael Fuegl, Ludwig Heitzer, Stefan Woetzel
  • Publication number: 20230361009
    Abstract: A semiconductor package is disclosed. In one example, the semiconductor package comprises a package body and a second die pad at least partially encapsulated in the package body. A first semiconductor die is at least partially encapsulated in the package body and arranged on the first die pad. A further device at least partially encapsulated in the package body and arranged on the second die pad. At least one first lead is connected with the first contact pad of the first semiconductor die. At least one second lead is connected with the second contact pad of the further device. An electrical conductor is connected between the at least one first lead and the at least one second lead, the electrical conductor being completely encapsulated in the package body.
    Type: Application
    Filed: May 9, 2023
    Publication date: November 9, 2023
    Applicant: Infineon Technologies AG
    Inventors: Lee Shuang WANG, Marta ALOMAR DOMINGUEZ, Marcus BÖHM, Edward FÜRGUT, Chii Shang HONG, Teck Sim LEE, Bernd SCHMOELZER
  • Patent number: 11787767
    Abstract: Methods are provided for modulating MRGPR X4 generally, or for treating a MRGPR X4 dependent condition more specifically, by contacting the MRGPR X4 or administering to a subject in need thereof, respectively, an effective amount of a compound having the structure of Formula (I): or a pharmaceutically acceptable isomer, racemate, hydrate, solvate, isotope, or salt thereof, wherein m, n, p, t, A, B, Z, R1, R2 and R3 are as defined herein. Pharmaceutical compositions containing such compounds, as well as to compounds themselves, are also provided.
    Type: Grant
    Filed: April 15, 2021
    Date of Patent: October 17, 2023
    Assignee: ESCIENT PHARMACEUTICALS, INC.
    Inventors: Marcos Sainz, Adam Yeager, Brandon Selfridge, Esther Martinborough, Marcus Boehm, Liming Huang
  • Publication number: 20230303567
    Abstract: Methods are provided for modulating MRGPRX2 generally, or for treating a MRGPRX2 dependent condition more specifically, by contacting the MRGPRX2 or administering to a subject in need thereof, respectively, an effective amount of a compound having structure (I): or a pharmaceutically acceptable salt, isomer, hydrate, solvate or isotope thereof, wherein A, B, C, D, E, G, W, Y, Z, R1, R2, R3, R4, R5, R6, R7 and R8 are as defined herein. Pharmaceutical compositions containing such compounds, as well as the compounds themselves, are also provided.
    Type: Application
    Filed: February 15, 2023
    Publication date: September 28, 2023
    Inventors: Marion Lanier, Marcos Sainz, Marcus Boehm, Liming Huang, Esther Martinborough, Brandon Selfridge, Adam Yeager
  • Publication number: 20230178462
    Abstract: A transistor package includes a semiconductor transistor chip having opposite first and second surfaces, one or a plurality of first load electrodes, one or a plurality of second load electrodes, and a control electrode on the first surface. A leadframe faces the first surface of the semiconductor transistor chip and includes a first terminal, a second terminal, and a control terminal of the package which are exposed at a bottom of the package. The first terminal is electrically coupled to the first load electrode(s). The second terminal is electrically coupled to the second load electrode(s). The control terminal is electrically coupled to the control electrode. The first terminal is aligned with a first side of the package. The second terminal is aligned with a second side opposite the first side. The control terminal is aligned with a third side of the package which connects between the first and second sides.
    Type: Application
    Filed: November 22, 2022
    Publication date: June 8, 2023
    Inventors: Stefan Wötzel, Marcus Böhm
  • Patent number: 11667636
    Abstract: Methods are provided for modulating MRGPRX2 generally, or for treating a MRGPRX2 dependent condition more specifically, by contacting the MRGPRX2 or administering to a subject in need thereof, respectively, an effective amount of a compound having structure (I): or a pharmaceutically acceptable salt, isomer, hydrate, solvate or isotope thereof, wherein A, B, C, D, E, G, W, Y, Z, R1, R2, R3, R4, R5, R6, R7 and R8 are as defined herein. Pharmaceutical compositions containing such compounds, as well as the compounds themselves, are also provided.
    Type: Grant
    Filed: December 22, 2021
    Date of Patent: June 6, 2023
    Assignee: ESCIENT PHARMACEUTICALS, INC.
    Inventors: Marion Lanier, Marcos Sainz, Marcus Boehm, Liming Huang, Esther Martinborough, Brandon Selfridge, Adam Yeager
  • Publication number: 20230160557
    Abstract: The invention relates to a light-emitting component, comprising: at least one conversion element comprising: at least one first material selected from the group consisting of polyazene, rubrene and derivatives thereof; at least one second material, the second material being a quantum dot, and at least one light source, the at least one light source emitting at least one photon in the range of 3.5 eV to 2.5 eV, preferably in the range of 3.0 eV to 2.55 eV. The invention further relates to the use of a light-emitting component according to the invention.
    Type: Application
    Filed: October 22, 2019
    Publication date: May 25, 2023
    Inventors: Ion STOLL, Marcus BOEHM
  • Publication number: 20230159474
    Abstract: Methods are provided for modulating MRGPR X4 generally, or for treating a MRGPR X4 dependent condition more specifically, by contacting the MRGPR X4 or administering to a subject in need thereof, respectively, an effective amount of a compound having the structure of Formula (I): or a pharmaceutically acceptable isomer, racemate, hydrate, solvate, isotope, or salt thereof, wherein n, x, A, Q1, Q2, Z, R, R1, R2, R3, R4 and R5 are as defined herein. Pharmaceutical compositions containing such compounds, as well as to compounds themselves, are also provided.
    Type: Application
    Filed: July 6, 2022
    Publication date: May 25, 2023
    Inventors: Adam Yeager, Brandon Selfridge, Marcos Sainz, Esther Martinborough, Marcus Boehm, Liming Huang
  • Patent number: 11643399
    Abstract: Methods are provided for modulating MRGPR X4 generally, or for treating a MRGPR X4 dependent condition more specifically, by contacting the MRGPR X4 or administering to a subject in need thereof, respectively, an effective amount of a compound having the structure of Formula (I): or a pharmaceutically acceptable isomer, racemate, hydrate, solvate, isotope, or salt thereof, wherein n, x, A, Q1, Q2, Z, R, R1, R2, R3, R4 and R5 are as defined herein. Pharmaceutical compositions containing such compounds, as well as to compounds themselves, are also provided.
    Type: Grant
    Filed: November 19, 2021
    Date of Patent: May 9, 2023
    Assignee: ESCIENT PHARMACEUTICALS, INC.
    Inventors: Adam Yeager, Brandon Selfridge, Marcos Sainz, Esther Martinborough, Marcus Boehm, Liming Huang
  • Publication number: 20230065217
    Abstract: Methods are provided for modulating MRGPR X2 generally, or for treating a MRGPR X2 or a MRGPR X2 ortholog dependent condition, more specifically, by contacting the MRGPR X2 or the MRGPR X2 ortholog by administering to a subject in need thereof, respectively, an effective amount of a compound having structure (I): or a pharmaceutically acceptable salt, isomer, hydrate, solvate or isotope thereof, wherein W, Z, R1, R2, R3, R4, R5, R6 and Rx are as defined herein. Pharmaceutical compositions containing such compounds, as well as the compounds themselves, are also provided.
    Type: Application
    Filed: September 24, 2021
    Publication date: March 2, 2023
    Inventors: Marion Lanier, Marcus Boehm, Liming Huang, Esther Martinborough, Marcos Sainz, Brandon Selfridge, Adam Yeager
  • Publication number: 20230053860
    Abstract: Methods are provided for modulating MRGPR X4 generally, or for treating a MRGPR X4 dependent condition more specifically, by contacting the MRGPR X4 or administering to a subject in need thereof, respectively, an effective amount of a compound having the structure of Formula (I): or a pharmaceutically acceptable isomer, racemate, hydrate, solvate, isotope, or salt thereof, wherein n, x, A, Q1, Q2, Z, R, R1, R2, R3, R4 and R5 are as defined herein. Pharmaceutical compositions containing such compounds, as well as to compounds themselves, are also provided.
    Type: Application
    Filed: November 19, 2021
    Publication date: February 23, 2023
    Inventors: Adam Yeager, Brandon Selfridge, Marcos Sainz, Esther Martinborough, Marcus Boehm, Liming Huang
  • Publication number: 20220340559
    Abstract: Methods are provided for modulating MRGPRX2 generally, or for treating a MRGPRX2 dependent condition more specifically, by contacting the MRGPRX2 or administering to a subject in need thereof, respectively, an effective amount of a compound having structure (I): or a pharmaceutically acceptable salt, isomer, hydrate, solvate or isotope thereof, wherein A, B, C, D, E, G, W, Y, Z, R1, R2, R3, R4, R5, R6, R7 and R8 are as defined herein. Pharmaceutical compositions containing such compounds, as well as the compounds themselves, are also provided.
    Type: Application
    Filed: December 22, 2021
    Publication date: October 27, 2022
    Inventors: Marion Lanier, Marcos Sainz, Marcus Boehm, Liming Huang, Esther Martinborough, Brandon Selfridge, Adam Yeager
  • Publication number: 20220340530
    Abstract: Methods are provided for modulating MRGPRX2 generally, or for treating a MRGPRX2 dependent condition more specifically, by contacting the MRGPRX2 or administering to a subject in need thereof, respectively, an effective amount of a compound having structure (I): or a pharmaceutically acceptable salt, isomer, hydrate, solvate or isotope thereof, wherein D, W, Z, R1, R2 and R3 are as defined herein. Pharmaceutical compositions containing such compounds, as well as the compounds themselves, are also provided.
    Type: Application
    Filed: December 8, 2021
    Publication date: October 27, 2022
    Inventors: Marion Lanier, Marcus Boehm, Liming Huang, Esther Martinborough, Marcos Sainz, Brandon Selfridge, Adam Yeager
  • Publication number: 20220177434
    Abstract: Methods are provided for modulating MRGPRX2 or a MRGPRX2 ortholog generally, or for treating a MRGPRX2 or a MRGPRX2 ortholog dependent condition more specifically, by contacting the MRGPRX2 or the MRGPRX2 ortholog by administering to a subject in need thereof, respectively, an effective amount of a compound having structure (I): or a pharmaceutically acceptable salt, isomer, hydrate, solvate or isotope thereof, wherein W, Z, R1, R2, R3, R4, R5, R6 and Rx are as defined herein. Pharmaceutical compositions containing such compounds, as well as the compounds themselves, are also provided.
    Type: Application
    Filed: October 20, 2021
    Publication date: June 9, 2022
    Inventors: Marion Lanier, Marcus Boehm, Liming Huang, Esther Martinborough, Marcos Sainz, Brandon Selfridge, Adam Yeager
  • Publication number: 20210340106
    Abstract: Methods are provided for modulating MRGPR X4 generally, or for treating a MRGPR X4 dependent condition more specifically, by contacting the MRGPR X4 or administering to a subject in need thereof, respectively, an effective amount of a compound having the structure of Formula (I): or a pharmaceutically acceptable isomer, racemate, hydrate, solvate, isotope, or salt thereof, wherein m, n, p, t, A, B, Z, R1, R2 and R3 are as defined herein. Pharmaceutical compositions containing such compounds, as well as to compounds themselves, are also provided.
    Type: Application
    Filed: April 15, 2021
    Publication date: November 4, 2021
    Inventors: Marcos Sainz, Adam Yeager, Brandon Selfridge, Esther Martinborough, Marcus Boehm, Liming Huang
  • Publication number: 20210261860
    Abstract: A method for producing an optoelectronic semiconductor component and an optoelectronic component are disclosed. In an embodiment a method includes providing an optoelectronic semiconductor chip comprising at least one light-emitting layer and at least one cavity and introducing at least one precursor of a conversion element in the at least one cavity, wherein the at least one conversion element comprises a perovskite-based ABX3 or A2BB?X6 structure.
    Type: Application
    Filed: July 24, 2019
    Publication date: August 26, 2021
    Inventors: Marcus Boehm, Britta Goeoetz, Martin Strassburg
  • Publication number: 20210225744
    Abstract: A package includes a carrier, an electronic component on the carrier, an encapsulant encapsulating at least part of the carrier and the electronic component, and at least one lead extending beyond the encapsulant and having a punched surface, wherein at least part of at least one side flank of the encapsulant has a sawn texture.
    Type: Application
    Filed: January 15, 2021
    Publication date: July 22, 2021
    Inventors: Frank Singer, Marcus Boehm, Andreas Grassmann, Martin Gruber, Uwe Schindler
  • Publication number: 20210032213
    Abstract: Methods are provided for modulating MRGPR X4 generally, or for treating a MRGPR X4 dependent condition more specifically, by contacting the MRGPR X4 or administering to a subject in need thereof, respectively, an effective amount of a compound having the structure of Formula (I). or a pharmaceutically acceptable isomer, racemate, hydrate, solvate, isotope, or salt thereof, wherein n, x, A, Q1, Q2, Z, R, R1, R2, R3, R4 and R5 are as defined herein. Pharmaceutical compositions containing such compounds, as well as to compounds themselves, are also provided.
    Type: Application
    Filed: March 26, 2020
    Publication date: February 4, 2021
    Inventors: Adam Yeager, Brandon Selfridge, Marcos Sainz, Esther Martinborough, Marcus Boehm, Liming Huang